Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.

Saved in:
Bibliographic Details
Title: Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Authors: Haley CA; Southeastern National Tuberculosis Center, Division of Infectious Diseases and Global Medicine, Department of Medicine in the College of Medicine, University of Florida, Gainesville, Florida, USA.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Schechter MC; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; Georgia State Tuberculosis Program, Atlanta, Georgia, USA., Ashkin D; Southeastern National Tuberculosis Center, Division of Infectious Diseases and Global Medicine, Department of Medicine in the College of Medicine, University of Florida, Gainesville, Florida, USA., Peloquin CA; Translational Research, College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA., Peter Cegielski J; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Andrino BB; Fairfax County Health Department, Annandale, Virginia, USA., Burgos M; New Mexico Department of Health, Santa Fe, New Mexico, USA.; University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.; New Mexico Veterans Affairs Health Care System, Albuquerque, New Mexico, USA., Caloia LA; Louisville Metro Department of Public Health and Wellness, Louisville, Kentucky, USA.; Humana Healthy Horizons in Kentucky, Louisville, Kentucky, USA., Chen L; Curry International Tuberculosis Center, University of California, San Francisco, California, USA., Colon-Semidey A; Puerto Rico Department of Health, San Juan, Puerto Rico, USA., DeSilva MB; Saint Paul-Ramsey County Public Health, Saint Paul, Minnesota, USA.; HealthPartners Institute, Bloomington, Minnesota, USA., Dhanireddy S; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA., Dorman SE; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.; South Carolina Department of Health and Environmental Control, Greenville, South Carolina, USA., Dworkin FF; New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York, New York, USA., Hammond-Epstein H; Southeastern National Tuberculosis Center, University of Florida, Gainesville, Florida, USA., Easton AV; New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York, New York, USA., Gaensbauer JT; Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ghassemieh B; Public Health-Seattle & King County, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Gomez ME; Southeastern National Tuberculosis Center, University of Florida, Gainesville, Florida, USA., Horne D; Pulmonary, Critical Care and Sleep Medicine, Harborview Medical Center, University of Washington, Seattle, Washington, USA., Jasuja S; Cook County Department of Public Health, Forest Park, Illinois, USA., Jones BA; Bureau of Public Health Laboratories, Florida State Tuberculosis Program, Jacksonville, Florida, USA., Kaplan LJ; Division of Infectious Diseases, Department of Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA., Khan AE; Jefferson County Department of Health, Birmingham, Alabama, USA., Kracen E; Public Health-Seattle & King County, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Labuda S; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Puerto Rico Department of Health, San Juan, Puerto Rico, USA., Landers KM; Alabama Department of Public Health, Montgomery, Alabama, USA., Lardizabal AA; Global Tuberculosis Institute, Rutgers University, Newark, New Jersey, USA., Lasley MT; Southeastern National Tuberculosis Center, University of Florida, Gainesville, Florida, USA., Letzer DM; Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Lopes VK; Sheboygan County Health and Human Services, Sheboygan, Wisconsin, USA.; Southern California Infectious Diseases Associates, Inc., Newport Beach, California, USA., Lubelchek RJ; Cook County Department of Public Health, Forest Park, Illinois, USA.; Division of Infectious Diseases, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA.; Department of Medicine, Rush University Medical Center, Chicago, Illinois, USA., Patricia Macias C; Health Transformation Program NorthShore University, Chicago, Illinois, USA.; The International Union Against Tuberculosis and Lung Disease, Paris, France., Mihalyov A; Louisville Metro Department of Public Health and Wellness, Louisville, Kentucky, USA., Misch EA; Division of Infectious Disease, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Murray JA; Emergency Medicine, Saint Elizabeth Healthcare System, Edgewood, Kentucky, USA.; Northern Kentucky Health Department, Florence, Kentucky, USA., Narita M; Public Health-Seattle & King County, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Nilsen DM; New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, New York, New York, USA., Ninneman MJ; Jackson Memorial Hospital, Miami, Florida, USA., Ogawa L; Saint Paul-Ramsey County Public Health, Saint Paul, Minnesota, USA., Oladele A; Dekalb County Tuberculosis Program, Decatur, Georgia, USA., Overman M; South Carolina Department of Health and Environmental Control, Greenville, South Carolina, USA., Ray SM; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; Georgia State Tuberculosis Program, Atlanta, Georgia, USA., Ritger KA; Chicago Department of Public Health, Chicago, Illinois, USA., Rowlinson MC; Bureau of Public Health Laboratories, Florida State Tuberculosis Program, Jacksonville, Florida, USA.; Wadsworth Center, New York State Department of Health, Albany, New York, USA., Sabuwala N; Minnesota Department of Health, Saint Paul, Minnesota, USA., Schiller TM; Winnebago County Health Department, Rockford, Illinois, USA., Schwartz LE; Tacoma-Pierce County Health Department, Tacoma, Washington, USA., Spitters C; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.; Snohomish County Health Department, Everett, Washington, USA.; Washington State Department of Health, Shoreline, Washington, USA., Thomson DB; Barren River District Health Department, Bowling Green, Kentucky, USA., Tresgallo RR; Department of Medicine, University of Miami, Jackson Memorial Hospital, Miami, Florida, USA., Valois P; Bureau of Public Health Laboratories, Florida State Tuberculosis Program, Jacksonville, Florida, USA., Goswami ND; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Corporate Authors: BPaL Implementation Group
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Oct 05; Vol. 77 (7), pp. 1053-1062.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciad312